bnt211
biontech
['bnt211']
"for patients [with testicular cancer] who don t achieve that upfront cure there hasn t been a recent advancement in therapies." - david a. braun, md, phd, on new data from the phase 1/2 trial of bnt211, a combination car t-cell/carvac therapy. #esmo22 
CGTLive™ delivers quality and relevant information to healthcare professionals on cell, gene, regenerative, and engineered medicines to ultimately improve care.